Showing results (901-910 of 1,022) with videos related to

Sort By:
Pageof 103
JAMA Psychiatry|July 5, 2018
Association of Prenatal Exposure to Population-Wide Folic Acid Fortification With Altered Cerebral Cortex Maturation in YouthsHamdi Eryilmaz, Kevin F Dowling, Franklin C Huntington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancerUrsula A Matulonis, Suzanne Berlin, Percy Ivy, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2019
A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantationJoshua A Cohen, E Kevin Heist, Jennifer Galvin, et al.
Journal of the American Heart Association|September 27, 2021
Age and Phenotype of Patients With Plaque ErosionMakoto Araki, Taishi Yonetsu, Osamu Kurihara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver DiseaseTakara L Stanley, Lindsay T Fourman, Lai Ping Wong, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2018
Design, synthesis and biological evaluation of glutamic acid derivatives as anti-oxidant and anti-inflammatory agentsSuvarna H Pagire, Eunhye Lee, Haushabhau S Pagire, et al.
Thrombosis and Haemostasis|February 15, 2018
Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary SyndromeLeonardo P de Carvalho, Alan Fong, Richard Troughton, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
Pageof 103